Dr. Halima Amjad
Geriatrics
1 Podcast on BackTable
Dr. Halima Amjad is a geriatrician at the Johns Hopkins University School of Medicine in Baltimore, Maryland.
Learn from the experiences and expertise of Dr. Halima Amjad and other leading voices in your specialty on the BackTable app.
Episode # 511 • 12 Jan 2026
Alzheimer’s Disease: Updates in Diagnosis & Treatment
From blood-based biomarkers to anti-amyloid treatments, join us as we explore the latest in Alzheimer’s disease diagnosis and treatment with Dr. Halima Amjad. This episode will equip you to guide your patients about the latest Alzheimer’s diagnostics as well as eligibility, risks and monitoring for anti-amyloid therapies.
More from Dr. Halima Amjad
About
Dr. Halima Amjad is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. Her clinical expertise in geriatric medicine focuses on the diagnosis, treatment, and care for individuals living with dementia.
Dr. Amjad earned her M.D. and Master’s of Public Health from Drexel University. She completed her residency and chief residency in internal medicine at Yale-New Haven Hospital and a fellowship in geriatric medicine and gerontology at Johns Hopkins University School of Medicine. She joined the faculty of Johns Hopkins in 2016. She completed a PhD in Clinical Investigation at the Johns Hopkins University Bloomberg School of Public Health in 2022.
She conducts health services research focuses on informing and improving the care of older adults with dementia with research into underdiagnosis, hospitalization, and primary care in dementia.
Visit Johns Hopkins Medicine to learn more about Dr. Halima Amjad.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.